The North America Bio Pharmaceuticals market was worth $56.49 billion in 2016 and estimated to be growing at a CAGR of 8.75%, to reach $85.92 billion by 2021. North America has the highest market share for the projected period owing to presence of refined healthcare infrastructure, rising geriatric population base and augmented healthcare expenditure in the region.
Mostly biopharmaceuticals products are derived from life forms or genetically modified plants and animals known as ... Read more
